Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Resiliency and Exercise Using AI-based Messaging: The DREAM Pilot Study

NCT07225283 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07225283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07225283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Resiliency and Exercise Using AI-based Messaging: The DREAM Pilot Study
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
March 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2